𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Melanoma-associated antigens MAGE-3, melan A/MART-1 and tyrosinase: distribution in primary and metastatic melanoma and regulation by interferons

✍ Scribed by Hofbauer, G.; Kamarashey, J.; Geertsen, R.; Böni, R.; Dummer, R.

Book ID
119562413
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
187 KB
Volume
16
Category
Article
ISSN
0923-1811

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Stimulation of CD8+ T cell responses to
Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine
✍ Sandra R. Reynolds; Ruth Oratz; Richard L. Shapiro; Phyllis Hao; Zhang Yun; Mari 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 85 KB

A critical requirement for cancer vaccines is that they stimulate CD8 ؉ T cell responses. In this study, we tested the ability of a polyvalent melanoma vaccine to induce CD8 ؉ T cell responses to the melanoma associated antigens MAGE-3 and Melan A/MART-1. Fifteen HLA-A2 ؉ patients with resected mali

High homogeneity of MAGE, BAGE, GAGE, Ty
High homogeneity of MAGE, BAGE, GAGE, Tyrosinase and Melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: Implications for protocol design of therapeutic antigen-specific vaccination strategies
✍ Piero Dalerba; Axel Ricci; Vincenzo Russo; Donata Rigatti; Maria Rita Nicotra; M 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 58 KB 👁 2 views

Human melanoma cells express several antigens which are recognized by autologous and specific CTL clones in association with HLA-class-I molecules. Many of these antigens represent suitable targets for tumor immunotherapy, since their expression in human melanoma cells is common and highly specific.

Tumor regressions observed in patients w
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
✍ Marie Marchand; Nicolas van Baren; Patrick Weynants; Vincent Brichard; Brigitte 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 886 KB

Thirty-nine tumor-bearing patients with metastatic melanoma were treated with 3 subcutaneous injections of the MAGE-3.A1 peptide at monthly intervals. No significant toxicity was observed. Of the 25 patients who received the complete treatment, 7 displayed significant tumor regressions. All but one

Peptide-specific ctl in tumor-infiltrati
Peptide-specific ctl in tumor-infiltrating lymphocytes from metastatic melanomas expressing mart-1/melan-a, gp100 and tyrosinase genes: A study in an unselected group of hla-a2.1-positive patients
✍ Giulio C. Spagnoli; Christoph Schaefer; Thomas E. Willimann; Thomas Kocher; Anto 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 935 KB

Peptide specificity of cultured tumor-infiltrating lymphocytes (TIL) was systematically investigated in a group of HLA-A2. I + metastatic melanoma patients consecutively referred to our department for surgical treatment. Seven samples from 6 patients were studied. All surgical specimens showed evide